- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Biosig-Aktien steigen nach Anhebung des Kursziels durch Ascendiant Capital | 1 | Investing.com Deutsch | ||
| Fr | Biosig shares soar on Ascendiant Capital target raise | 1 | Investing.com | ||
| Fr | Ascendiant Capital erhöht Kursziel für BioSig Technologies-Aktie | 3 | Investing.com Deutsch | ||
| Mi | BioSig Technologies ernennt Sean Roosen zum strategischen Berater | 1 | Investing.com Deutsch | ||
| Mi | BioSig Technologies, Inc.: BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor | 1 | GlobeNewswire (USA) | ||
| 30.05. | A commodities blockchain company is using BioSig to go public | 2 | MassDevice | ||
| 28.05. | BioSig ernennt Mitch Williams zum Chief Investment Officer | 1 | Investing.com Deutsch | ||
| 28.05. | BioSig appoints Mitch Williams as Chief Investment Officer | 1 | Investing.com | ||
| BIOSIG TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 28.05. | BioSig Technologies, Inc.: BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer | 230 | GlobeNewswire (Europe) | Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "combined company"), which today acquired Streamex Exchange Corporation... ► Artikel lesen | |
| 28.05. | BioSig Technologies, Inc.: Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq | 140 | GlobeNewswire (Europe) | Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as... ► Artikel lesen | |
| 27.05. | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.05. | BioSig Stock Surges Following Share Exchange Deal With Streamex | 1 | Zacks | ||
| 26.05. | BioSig Technologies enters agreement to merge with Streamex Exchange | 1 | Seeking Alpha | ||
| 26.05. | BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition | 1 | Insider Monkey | ||
| 24.05. | BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. | 5 | GlobeNewswire (USA) | ||
| 19.05. | BioSig Technologies, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 15.05. | BioSig Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.05. | BioSig to merge with Streamex, forming public real-world asset tokenization firm | 3 | Seeking Alpha | ||
| 05.05. | BioSig fusioniert mit Streamex in reiner Aktientransaktion | 2 | Investing.com Deutsch | ||
| 05.05. | BioSig to merge with Streamex in all-stock deal | 1 | Investing.com |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,111 | 0,00 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,800 | +8,40 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
| PING AN HEALTHCARE | 0,755 | 0,00 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
| MOUNTAIN VALLEY MD | 0,012 | -16,44 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,274 | +3,01 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,525 | -3,40 % | Veru Inc.: Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide ... | --Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial... ► Artikel lesen | |
| CYTOSORBENTS | 0,884 | -4,54 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 5,240 | -100,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| VOLITIONRX | 0,568 | -3,57 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen | |
| EKSO BIONICS | 0,257 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.06.2025 | The following instruments on XETRA do have their first trading 02.06.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.06.2025
Aktien
1 LU0445408270 Altisource Portfolio... ► Artikel lesen | |
| IMUNON | 1,340 | +1,52 % | IMNN-001 shows promise in ovarian cancer treatment | ||
| BEYOND AIR | 0,158 | -1,86 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 46,650 | +0,26 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 44,290 | +0,11 % | DAX-Check LIVE: Bilfinger, Cancom, Delivery Hero, Fresenius, Gerresheimer, Rheinmetall im Fokus | Der DAX hat den gestrigen Handelstag mit leichten Verlusten beendet. Der deutsche Leitindex schloss 0,28 Prozent tiefer bei 23.930 Punkten. Zwar konnte er sich am Nachmittag vom Tagestief bei 23.740... ► Artikel lesen |
BIOSIG TECHNOLOGIES INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +24,30 % bei einem Aktienkurs von 7,135 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOSIG TECHNOLOGIES INC finden Sie auf Wallstreet Online.